These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24225047)

  • 1. [Cytolysis in an elderly patient treated with dabigatran etexilate].
    Fulcrand J; Lerooy A; Giraud J; Cailliau A; Delrot C; Petitpain N; Auffret M;
    Therapie; 2013; 68(5):332-4. PubMed ID: 24225047
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
    Béné J; Saïd W; Rannou M; Deheul S; Coupe P; Gautier S
    Ann Pharmacother; 2012 Jun; 46(6):e14. PubMed ID: 22669799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of dabigatran in elderly patients.
    Legrand M; Mateo J; Aribaud A; Ginisty S; Eftekhari P; Huy PT; Drouet L; Payen D
    Arch Intern Med; 2011 Jul; 171(14):1285-6. PubMed ID: 21788545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran etexilate linked to fatal gastrointestinal hemorrhage.
    Feinberg J; Grabowitz L; Rotman-Pikielny P; Berla M; Levy Y
    Isr Med Assoc J; 2014 Jun; 16(6):388-9. PubMed ID: 25059005
    [No Abstract]   [Full Text] [Related]  

  • 5. Dabigatran: a cause of hematologic emergency.
    Lal Y; Van Heukelom J
    Am J Med Sci; 2013 Sep; 346(3):190-3. PubMed ID: 23221509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage.
    Carter A; Sarda P; George M; Corbett S
    Ann R Coll Surg Engl; 2014 Jan; 96(1):115E-117E. PubMed ID: 24417860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance.
    Ahmad Y; Lip GY
    Heart; 2012 Oct; 98(19):1404-6. PubMed ID: 22698856
    [No Abstract]   [Full Text] [Related]  

  • 8. Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.
    Wilcox R; Pendleton RC; Smock KJ; Rodgers GM
    Hosp Pract (1995); 2011 Aug; 39(3):23-34. PubMed ID: 21881389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding with dabigatran (Pradaxa).
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):98. PubMed ID: 22173427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
    Fellows SE; Rosini JM; Curtis JA; Volz EG
    J Emerg Med; 2013 Feb; 44(2):e221-5. PubMed ID: 22595629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW; Zimetbaum PJ
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1461-71. PubMed ID: 24147516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New anticoagulant drugs among elderly patients is caution necessary?: Comment on "The use of dabigatran in elderly patients".
    Jacobs JM; Stessman J
    Arch Intern Med; 2011 Jul; 171(14):1287-8. PubMed ID: 21788546
    [No Abstract]   [Full Text] [Related]  

  • 13. Dabigatran-induced acute hepatitis.
    Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
    Garza R; Huo MH
    Expert Rev Cardiovasc Ther; 2012 Apr; 10(4):423-7. PubMed ID: 22458575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No(AC) free lunches: promises and pitfalls of novel oral anticoagulants.
    Ellis MH
    Isr Med Assoc J; 2014 Jun; 16(6):377-8. PubMed ID: 25059002
    [No Abstract]   [Full Text] [Related]  

  • 17. Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa).
    Nguyen TM; Phelan MP; Werdich XQ; Rychwalski PJ; Huff CM
    Am J Emerg Med; 2013 Feb; 31(2):455.e3-5. PubMed ID: 23000334
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.
    Eriksson BI; Dahl OE; Ahnfelt L; Kälebo P; Stangier J; Nehmiz G; Hermansson K; Kohlbrenner V
    J Thromb Haemost; 2004 Sep; 2(9):1573-80. PubMed ID: 15333033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of dabigatran-associated bleeding: case report and review of the literature.
    Harinstein LM; Morgan JW; Russo N
    J Pharm Pract; 2013 Jun; 26(3):264-9. PubMed ID: 23160864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran in clinical practice.
    Nagarakanti R; Ellis CR
    Clin Ther; 2012 Oct; 34(10):2051-60. PubMed ID: 23031622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.